Gilead Sciences On Pace for Lowest Close Since October 2013 -- Data Talk

Gilead Sciences, Inc. (GILD) is currently at $60.31, down $0.24 or 0.4%

-- Would be the lowest close since Oct. 9, 2013, when it closed at $58.90; surpassing its closing low on Dec. 24, 2018, when it closed at $60.54

-- Currently down seven consecutive days; down 6.57% over this period

-- Late last week, the World Health Organization released interim results from an international study of Covid treatments, including remdesivir. To Gilead's dismay, the October 15 report from the WHO study said that remdesivir made no clear difference in mortality, the need for ventilators or the length of hospitalization, Barron's reported

-- Longest losing streak since Jan. 21, 2020, when it fell for seven straight trading days

-- Worst seven day stretch since the seven days ending Aug. 6, 2020, when it fell 6.67%

-- Down 4.56% month-to-date

-- Down 7.19% year-to-date; on pace for worst year since 2018, when it fell 12.69%

-- Down 50.65% from its all-time closing high of $122.21 on June 23, 2015

-- Down 9.42% from 52 weeks ago (Oct. 23, 2019), when it closed at $66.58

-- Down 28.2% from its 52 week closing high of $84.00 on April 30, 2020

-- Would be a new 52 week closing low

-- Traded as low as $59.90

-- Down 1.07% at today's intraday low

All data as of 12:28:43 PM

Source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

October 21, 2020 12:52 ET (16:52 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.